Glutamate-Glutamate-Methionine-Glutamine-Arginine-Arginine-Alanine-Aspartate-NH₂, has emerged as a notable synthetic p...
What was the scientific moment or data point that convinced you NK cell–derived extracellular vesicles could becom...
Why does TAXIS choose to focus on antimicrobial resistance? What are the key developments taking place at TAXIS to comba...
Singapore has one of the most advanced biotechnology industries. Singapore began building its biomedical sciences ecosys...
Life sciences M&A accelerated in 2025, with deal sizes increasing and total spend surpassing 2024 levels before the ...
How would KBI Biopharma highlight its achievements in 2025? Which key projects strengthened the company’s global C...
Significant strides have been made in the detection and treatment of cancer in the last two decades. However, while surv...
Asia-Pacific’s life sciences landscape has always been shaped by contrasts. It is a region where scale and sophist...
The Japanese government has stepped up efforts to strengthen its startup ecosystem, rolling out a series of initiatives ...
The World Health Organization (WHO) estimates that more than 2.2 billion people worldwide live with some form of vision ...
The COVID-19 pandemic acted as both a challenge and a catalyst, serving as a testbed that fundamentally reshaped the bio...
mRNA first entered the global spotlight during COVID-19, turning companies such as Moderna and BioNTech into household n...
Register Now Asia Pacific’s biomanufacturing landscape is entering a defining decade, and the ina...
China has reached a major milestone in global pharmaceutical innovation. According to the latest report from Clarivate, ...
According to reports, the APAC MedTech market is valued at $16.3 billion in 2025, with a potential to reach $18.6 billio...
Beyond tariff cuts, FTAs deliver deep structural benefits through regulatory alignment and facilitation of trade. Firms ...
In both the US and Japan, regulators provide an extensive set of resources detailing the rules and specifications govern...
For much of the past century, Alzheimer’s disease has been one of medicine’s most daunting frontiers—b...
The Asia-Pacific biotech sector is entering 2026 with renewed momentum. Investment in the pre-clinical organoid space co...
In today’s global, multi-provider clinical trial environment, sponsors need to rapidly and accurately assess vast ...
In 2026, oncology drug development in Asia may move away from the historical maximum tolerated dose (MTD) paradigm towar...
2025 was the year when China’s stratospheric rise on the global biotech stage continued. According to a report fro...
When Najat Khan steps into her new role as CEO and President of Recursion, she inherits more than a celebrated...
Puerto Rico’s transformation into a powerhouse of advanced biopharmaceutical manufacturing is gaining new momentum...
Artificial intelligence is rewriting the language of pathology, and Pictor Labs stands firmly at t...
API China, the China International Pharmaceutical Ingredients, Intermediates, Packaging and Equipment Trade Fair, offici...
In a special conversation with BioSpectrum Asia, Yang Huang, Head of China Healthcare Research at J.P. Morgan, shares sh...
Vietnam’s pharmaceutical market is expanding rapidly. According to Fitch Solutions, it was valued at $6 billion in...
A Chinese man who lost all four limbs in a high-voltage electrical accident 13 years ago can now play chess and racing g...
The vaccine landscape in Asia-Pacific is undergoing significant transformation and growth. While public-sector programme...
How does the Oncomine Dx Express Test Multi-CDx System improve on your earlier Oncomine Dx Target Test, and what impact ...
Ageing — the elusive truth of life, has long been debated by philosophers and tapped by the cosmetic industry. Mor...
Global demand for cell and gene therapies is rising, with the Asia-Pacific (APAC) region playing an increasingly signifi...
To effectively address the growing needs and evolving structure of this sector, DHL is investing €500 million into ...
In an exclusive conversation with BioSpectrum Asia, Christopher Ong, Managing Director of DHL Express Singapore, shares ...
Sharing his perspectives with BioSpectrum Asia, Narayana Rao Rapolu, Senior Vice President, Global Bioprocessing...
Australian biotech is known for its cutting-edge research, robust clinical trial activity, and favourable R&D infras...
Global interest in radiopharmaceuticals has surged in recent years, driven by a string of high-profile deals and rising ...
Day 2 of BIO Asia–Taiwan 2025 unfolded with palpable energy and a heightened sense of purpose as stakeholders from...
Cell and gene therapies are reshaping the landscape of modern medicine—but bringing these transformative treatment...
BioSpectrum Asia spoke to Dr Peter Fedichev, CEO of Gero, who explains how ProtoBind-Diff is transforming drug discovery...
It’s universally acknowledged that Asia-Pacific (APAC) is a hotbed for clinical trials, with multiple reports conf...
As Hong Kong accelerates its transformation into a global biotech and MedTech powerhouse, BioSpectrum ...
Ella Woger-Nieves, Chief Executive Officer of Invest Puerto Rico, spoke to BioSpectrum Asia and BioSpectrum Indi...
As the field shifts toward safer and more efficient gene delivery methods, PlasmidFactory’s proprietary technology...
The biopharma job market has been tough, with widespread downsizing and frequent layoffs across big pharma. But the wors...
Biotech partnerships of APAC differ in a variety of ways from most global collaborations, primarily due to the unique ge...
ICPI Week 2025 Wrap-Up ICPI WEEK 2025 WRAP-UP | BY MANBEENA CHAWLA, EXECUTIVE EDITOR, BIOSPECTRUM ASIA ...
Patients with non-proliferative diabetic retinopathy (NPDR) currently face a therapeutic gap—one that often leaves...
As an infectious diseases’ physician, clinical researcher and microbiologist, I have seen first-hand how new techn...
Biologics have fundamentally altered treatment strategies for a wide array of complex and chronic conditions, thanks to ...
Cloning ServicesPrecise and customized modification of plasmid DNA Replacement of antibiotic resistance genes c...
Asia-Pacific is driving a transformation in the global vaccine supply landscape. According to the WHO Vaccine Report 202...
The offering includes: €850 million floating rate notes, due March 2027, bearing interest at 3-month Eur...
Amid intensifying U.S.-China trade tensions, Beijing has escalated its retaliatory measures by banning U.S. biot...
"This transition is a testament to our commitment to both continuity and innovation," announced Merck KGaA, Darmstadt, G...
The region is focusing on innovation, collaboration, and commercialisation, to become a hotspot for healthcare solutions...
The global leader in eye care for over 75 years, Alcon strives to help eye care professionals strengthen their practices...
To recognise and celebrate the remarkable achievements and contributions of Asian companies and individuals in the life ...
In a recent conversation with Ankit Kankar from BioSpectrum Asia, Yvonne Lungershausen, CEO of Avance Clinical, shared i...
With Donald Trump’s return to the White House, the U.S.-China trade relationship is once again in the spotlight. T...
In an insightful interview with BioSpectrum Asia, Shaun Rothwell, CEO of EVŌQ Nano, reveals the transformative potentia...
The current wave of layoffs across the pharmaceutical and biotech sectors, affecting major companies like Pfizer...
In a candid conversation with Ankit Kankar from BioSpectrum Asia, Dr. Boro Dropulić, Executive Director of Caring Cross...
The biopharmaceutical and healthcare industries, long seen as cornerstones of innovation, are currently grappling with a...
Q: The usage of messenger RNA (mRNA) as novel active ingredient has attracted public attention in recent years, ...
The biotech industry, renowned for its rapid advancements and groundbreaking research, faced a significant wave of layof...
Over the past six months, the leading MedTech companies have made remarkable progress in product innovation, strategic p...
On July 1, 2024, Cytiva significantly bolstered its leadership team by appointing Pierre-Alain Ruffieux as Chief...
The Life Sciences Industry: Pitfalls and the Impact of Failed Clinical Trials in 2024 The life sciences industry is at ...
Ravindra Boratkar, Publisher & Managing Editor, BioSpectrum (India and Asia), NUFFOODS Spectrum (India and A...
The following report provides detailed analysis of Mergers and Acquisitions of BioPharma and Pharmaceuticals companies u...
A Shifting Landscape: The Bio Industry's May 2024 Layoffs May 2024 witnessed a wave of layoffs across the bio industry,...
The pharmaceutical and biotechnology industries are undergoing a significant upheaval, with a series of layoffs announce...
March 2024 has been marked by a series of layoffs in the biotech and pharmaceutical sector, raising concerns and drawing...
GlaxoSmithKline's (GSK) appointment of Emma Walmsley as CEO in 2016 made headlines for more than one reason. Notably, sh...
In February, the Biotech and BioPharma industries faced a wave of strategic layoffs, signaling a significant shift towar...
2024 comes with an 'extra' day for the life sciences industry to add up to its achievements and planning. While ‘L...
Pfizer: A Signal for a Reset? On January 2nd, Pfizer, a key player in the COVID vaccine race, initiated layoffs at ...
The treatment and management of blood cancers, in particular CLL, has advanced greatly in the last decade. Physicians an...
What makes purified gelatin the biomaterial of choice for embolization? Embolization, a medical procedure that in...
One of the biggest health news stories in recent months was a revolutionary therapy[1] that completely cleared a yo...
The power of biotech startups has proven to be enormous by BioNTech, during the pandemic, when its mRNA vaccines saved l...
With Asia Pacific (APAC) set to experience transformative growth, the need to build meaningful connections with microbio...
Some of these are extensions of trends observed in 2022 that will continue into 2023; such as Artificial Intelligence (A...
The rapid spread of the original virus strain and its subsequent variants across the globe highlighted the importance of...
Compensation is always tricky to determine, both as a professional and for organisations. Across all markets, individual...
How did the company perform in 2021? Eppendorf has managed to break its record of 2020 once again and to exceed the thr...
Women’s representation has improved across all levels of the corporate pipeline in 2020 and 2021, despite COVID-19...
Ageing is mostly associated with skin conditions like wrinkles, crows feet etc., and anti-ageing is considered a purview...
COVID-19 has upended the world and caused enormous challenges to economies and has brought terrible human suffering. Alm...
One of the silver linings of the COVID-19 pandemic has been the fast-tracked adoption of digital transformation across v...
Infectious diseases have been increasing in frequency during the past few decades. These include recurring outbreaks cau...
Recently the company celebrated its 100th anniversary. How has been the journey so far? It has been a deeply satisfyin...
Pre-pandemic, the Asia Pacific region was already becoming a preferred destination for clinical trial studies.1 P...
The burden of disease is used to calculate and estimate a population’s overall health. It can give some insight in...
The burden of cardiovascular diseases (CVDs) such as ischaemic heart disease, coronary artery disease, angina, stroke, r...
The race to full vaccination is the defining event of 2021. After a turbulent past year, Asia Pacific (APAC) regions are...
1. Better Access to Medical Care for U.S. Residents The Centers for Medicare and Medicaid Services (CMS) has put forth ...
This first DIA transnational conference will provide a holistic view on the clinical trial and regulatory space post-COV...
